Six-month (or first follow-up) outcome by allocation and by group
| Ruptured | Unruptured | All | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Cerecyte (n = 109) (No.) (%) | Bare Platinum (n = 112) (No.) (%) | P | Cerecyte (n = 119) (No.) (%) | Bare Platinum (n = 123) (No.) (%) | P | Cerecyte (n = 228) (No.) (%) | Bare Platinum (n = 235) (No.) (%) | P | |
| mRS 0 | 64 (58.7) | 62 (55.4)a | 93 (78.2)a | 100 (81.3)a | 157 (68.9) | 162 (68.9) | |||
| mRS 1 | 31 (28.4)b | 43 (38.4)b | 17 (14.3) | 16 (13.0) | 48 (21.1) | 59 (25.1) | |||
| mRS 2 | 8 (7.3) | 5 (4.5) | 4 (3.4) | 7 (5.7) | 12 (5.3) | 12 (5.1) | |||
| mRS 3 | 2 (1.8) | 0 (0.0) | 3 (2.5) | 0 (0.0) | 5 (2.2) | 0 (0.0) | |||
| mRS 4 | 1 (0.9) | 1 (0.9) | 1 (0.8) | 0 (0.0) | 2 (0.9) | 1 (0.4) | |||
| mRS 5 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |||
| Deathc | 3 (2.8) | 1 (0.9) | 1 (0.8) | 0 (0.0) | 4 (1.8) | 1 (0.4) | |||
| mRS ≥3, including deathd | 6 (5.5) | 2 (1.8) | .070 | 5 (4.2) | 0 (0.0) | 0.011 | 11 (4.8) | 2 (0.9) | .0049 |
↵a Four patients with mRS 0 had first follow-up at >12 months (14, 20, 21, and 22 months).
↵b Two patients with mRS 1 had first follow-up at >12 months (13 and 14 months).
↵c Causes of death: in-hospital: 1 delayed cerebral ischemia due to vasospasm, 1 postprocedural acute rebleed. Postdischarge: 1 pulmonary embolism, 1 coronary disease, and 1 respiratory.
↵d P values are for 1-sided Blackwelder tests.